Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 10, 2009BJU InternationalOpen Access

Impact of clinical factors, including a point‐of‐care nuclear matrix protein‐22 assay and cytology, on bladder cancer detection

View Full Paper
Ask AI
Bookmark
Share

Authors

Yair Lotan
Yair LotanNorthwestern UniversityUCUmberto CapitanioVita-Salute San Raffaele UniversitySSShahrokh F. ShariatSemmelweis University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lotan et al. (2009) studied this question.

synapsesocial.com/papers/6a6296d1fcd714155f097e6ahttps://doi.org/10.1111/j.1464-410x.2009.08360.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer Statistics, 20072007 · 7,474 citations
  2. 2Immunocyt Test Improves the Diagnostic Accuracy of Urinary Cytology: Results of a French Multicenter Study2003 · 139 citations
  3. 3Home Screening for Hematuria: Results of a Multi-Clinic Study1992 · 162 citations
  4. 4Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer2003 · 70 citations